Drugs / FMP1/AS02A
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00223990 | Apr 2005 → Apr 2006 | Plasmodium falciparum malaria | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMP1/AS02A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00223990 ↗ |
| Modality | Vaccine | “it constitutes the FMP1/AS02 candidate malaria vaccine.” PMID 19262754 ↗ Mar 2009 |
| Route | Intramuscular | “Vaccinations were administered intramuscularly (IM) in the left anterolateral thigh muscle” NCT00223990 ↗ |